Sequent Scientific Limited
Sequent Scientific Limited (SEQUENT.BO) Stock Overview
Explore Sequent Scientific Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
50.6B
P/E Ratio
123.30
EPS (TTM)
$1.64
ROE
0.10%
SEQUENT.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Sequent Scientific Limited (SEQUENT.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $247.15.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 123.30 and a market capitalization of 50.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.